Clinical guideline highlights for the hospitalist: Management of Kawasaki disease.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 35934950.
- Also identified by DOI 10.1002/jhm.12935.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease RELEASE DATE: March 7, 2022 PRIOR VERSION (S): 2017 DEVELOPER: American College of Rheumatology and the Vasculitis Foundation FUNDING SOURCE: American College of Rheumatology and the Vasculitis Foundation TARGET POPULATION: Children with Kawasaki disease.
Medical subject headings
- Hospitalists
- Mucocutaneous Lymph Node Syndrome
- Rheumatology
- Vasculitis